Report Description
The global contraceptive pills market size is projected to expand at a significant CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the imperative of reducing unplanned pregnancies and their consequences.
Contraceptives devices means to prevent pregnancy by using drugs or devices. It is also known as birth control and fertility control devices. Increasing use of contraceptives at home has improved health related outcomes. They can be attributed to robust government promotions and schemes for women and child health. These devices are also used for preventing transfer of sexually transmitted diseases or infections. Condoms are most preferred and hold a large market share in the world. Copper IUD is basically choice by the women for use the hormonal form to avoid possible side effects.
Market Trends, Drivers, Restraints, and Opportunities
- Rising use of contraception in young women is projected to boost the market growth in the coming years.
- Growing requirement for family planning solution is expected to spur the market growth during the forecast period.
- Rising incidence of abortion is projected to boost the market growth in the coming years.
- Increasing awareness of modern contraception is anticipated to drive the market growth during the forecast period.
- Rising use of oral pills to avoid unplanned pregnancy is projected to boost the market growth in the coming years.
- Lack of social acceptance is estimated to restrict the market growth.
- Increasing medical tourism in emerging nations is anticipated to create significant opportunities for the market players.
Scope of the Report
The report on the global contraceptive pills market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes | Details |
Report Title | Contraceptive Pills Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year | 2020 |
Historic Data | 2018–2019 |
Forecast Period | 2021–2028 |
Segmentation | Hormone Types (Progestin Pills and Combination Pills [Monophasic, Triphasic, and Others] and Categories (Generic and Branded) |
Regions | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report | Bayer AG; Abbvie Inc.; Amneal Pharmaceuticals LLC.; Amgen Inc.; Pfizer; and Teva |
Contraceptive Pills Market Segment Insights
Combination pills segment to hold a significant market share
Based on hormone types, the market is divided into progestin pills and combination pills. The combination pills are segmented into monophasic, triphasic, and others. The progestin pills segment is anticipated to hold a key share of the market in the coming years due to reduction in bleeding and possibly eliminate it. These pills reduce the risk of headaches. However, the combination pills segment is anticipated to expand at a rapid pace during the forecast period owing to decreased risk of ovarian and endometrial cancers, ectopic pregnancy, and ovarian cysts.
Branded segment is anticipated to hold a large market share
On the basis of categories, the market is segmented into generic and branded. The generic segment is projected to constitute a major market share during the forecast period due to their low prices and ease of use. On the other hand, the branded segment is anticipated to expand at a rapid pace during the forecast period owing to trust of consumers on them.
North America is estimated to account a major market share
On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a significant share of the market during the projected period owing to rapid developments in the healthcare infrastructure and high awareness about contraceptive pills in the region. However, the market in Asia Pacific is anticipated expand at a rapid pace during the forecast period owing to increasing focus on family planning among the population.
Segments
The global contraceptive pills market has been segmented on the basis of
Hormone Types
- Progestin Pills
- Combination Pills
- Monophasic
- Triphasic
- Others
Categories
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Bayer AG
- Abbvie Inc.
- Amneal Pharmaceuticals LLC.
- Amgen Inc.
- Pfizer
- Teva
Competitive Landscape
Key players competing in the global contraceptive pills market includes Bayer AG; Abbvie Inc.; Amneal Pharmaceuticals LLC.; Amgen Inc.; Pfizer; and Teva.
Some of these players are engaging in business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market share.
In India, Durex a Britain brand introduced a product range, named ‘Durex invisible condoms’ in October 2020 and claimed as India’s thinnest range of condom.

Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Contraceptive Pills Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Contraceptive Pills Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Contraceptive Pills Market - Supply Chain
4.5. Global Contraceptive Pills Market Forecast
4.5.1. Contraceptive Pills Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Contraceptive Pills Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Contraceptive Pills Market Absolute $ Opportunity
5. Global Contraceptive Pills Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Contraceptive Pills Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Contraceptive Pills Demand Share Forecast, 2019-2026
6. North America Contraceptive Pills Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Contraceptive Pills Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Contraceptive Pills Demand Share Forecast, 2019-2026
7. Latin America Contraceptive Pills Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Contraceptive Pills Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Contraceptive Pills Demand Share Forecast, 2019-2026
8. Europe Contraceptive Pills Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Contraceptive Pills Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Contraceptive Pills Demand Share Forecast, 2019-2026
9. Asia Pacific Contraceptive Pills Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Contraceptive Pills Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Contraceptive Pills Demand Share Forecast, 2019-2026
10. Middle East & Africa Contraceptive Pills Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Contraceptive Pills Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Contraceptive Pills Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Contraceptive Pills Market: Market Share Analysis
11.2. Contraceptive Pills Distributors and Customers
11.3. Contraceptive Pills Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Bayer AG
11.4.2.
Abbvie Inc.
11.4.3.
Amneal Pharmaceuticals LLC.
11.4.4.
Amgen Inc.
11.4.5.
Pfizer
11.4.6.
Teva